SQUASSINA, ALESSIO
 Distribuzione geografica
Continente #
EU - Europa 224.086
NA - Nord America 12.343
AS - Asia 6.264
SA - Sud America 1.281
AF - Africa 210
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 3
Totale 244.215
Nazione #
IT - Italia 220.836
US - Stati Uniti d'America 12.084
SG - Singapore 2.393
CN - Cina 1.950
BR - Brasile 975
VN - Vietnam 699
SE - Svezia 671
UA - Ucraina 517
DE - Germania 448
GB - Regno Unito 402
FI - Finlandia 353
FR - Francia 283
HK - Hong Kong 283
IN - India 175
CA - Canada 146
NL - Olanda 141
AR - Argentina 113
KR - Corea 112
BD - Bangladesh 94
MX - Messico 75
IQ - Iraq 68
JP - Giappone 67
TR - Turchia 65
AT - Austria 57
ZA - Sudafrica 56
ES - Italia 54
MA - Marocco 52
RU - Federazione Russa 51
PL - Polonia 50
EC - Ecuador 47
ID - Indonesia 40
BE - Belgio 38
CO - Colombia 37
SA - Arabia Saudita 33
VE - Venezuela 33
IE - Irlanda 31
PK - Pakistan 31
UZ - Uzbekistan 30
AU - Australia 27
PH - Filippine 26
CL - Cile 24
MY - Malesia 21
NO - Norvegia 21
CZ - Repubblica Ceca 20
IR - Iran 18
JO - Giordania 18
EG - Egitto 17
PY - Paraguay 17
AE - Emirati Arabi Uniti 16
LT - Lituania 16
AZ - Azerbaigian 13
IL - Israele 13
TN - Tunisia 13
DK - Danimarca 12
DZ - Algeria 12
KE - Kenya 12
KZ - Kazakistan 12
PE - Perù 12
PT - Portogallo 12
CH - Svizzera 11
BO - Bolivia 10
GR - Grecia 10
PS - Palestinian Territory 10
UY - Uruguay 10
NP - Nepal 9
ET - Etiopia 8
QA - Qatar 8
CI - Costa d'Avorio 7
KG - Kirghizistan 7
LB - Libano 7
RS - Serbia 7
SN - Senegal 7
TH - Thailandia 7
DO - Repubblica Dominicana 6
HR - Croazia 6
NG - Nigeria 6
OM - Oman 6
RO - Romania 6
GE - Georgia 5
MD - Moldavia 5
AM - Armenia 4
BG - Bulgaria 4
BY - Bielorussia 4
CR - Costa Rica 4
JM - Giamaica 4
NI - Nicaragua 4
PA - Panama 4
PR - Porto Rico 4
TW - Taiwan 4
AL - Albania 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
GT - Guatemala 3
IS - Islanda 3
KW - Kuwait 3
LV - Lettonia 3
TT - Trinidad e Tobago 3
BB - Barbados 2
CY - Cipro 2
Totale 244.167
Città #
Cagliari 214.530
Uta 5.408
Singapore 1.226
Ashburn 1.213
Fairfield 1.063
Dallas 911
San Jose 833
Woodbridge 765
Chandler 647
Houston 537
Boardman 475
Seattle 425
Wilmington 387
Beijing 371
Nyköping 348
Ann Arbor 340
Cambridge 338
New York 287
Los Angeles 276
Hong Kong 247
Jacksonville 242
Ho Chi Minh City 219
Helsinki 213
The Dalles 209
Santa Clara 176
Dearborn 175
Hefei 165
Lauterbourg 159
Shanghai 157
Council Bluffs 154
Hanoi 137
Boston 135
Nanjing 100
Seoul 99
Rome 97
São Paulo 92
Dong Ket 89
Buffalo 85
Frankfurt am Main 72
Orem 66
Munich 61
Chicago 60
San Diego 60
Cardiff 58
Tokyo 58
Atlanta 57
Nieuwegein 54
Redondo Beach 50
London 49
Redwood City 49
Montreal 48
Norwalk 47
Nuremberg 47
Guangzhou 46
Milan 46
Johannesburg 43
Chennai 42
Lappeenranta 40
Warsaw 40
Brussels 36
Amsterdam 35
Rio de Janeiro 35
Shenyang 35
Tianjin 35
Toronto 35
Brooklyn 34
Denver 34
Casablanca 33
Hebei 33
Poplar 33
Da Nang 32
Nanchang 32
Stockholm 32
Changsha 31
Jiaxing 30
Haiphong 27
Mexico City 26
Phoenix 26
Vienna 26
San Francisco 25
Tashkent 24
Turku 24
Dublin 23
Hangzhou 22
Zhengzhou 22
Baghdad 21
Mountain View 21
Naples 21
Pune 20
Manchester 19
Oslo 19
Guayaquil 18
Sassari 18
Shenzhen 18
Berlin 17
Brasília 17
City of London 17
Istanbul 17
Orange 17
Redmond 17
Totale 235.480
Nome #
Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients 4.363
Count of “dark telomere” on the track of a biomarker for lithium treatment in bipolar disorder 4.262
Major depression subtypes are differentially associated with migraine subtype, prevalence and severity 3.619
Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder 3.567
Pharmacogenetics of lithium effects on glomerular function in bipolar disorder patients under chronic lithium treatment: a pilot study 3.510
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.505
Challenges and Future Prospects of Precision Medicine in Psychiatry 3.423
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 3.138
Analysis of the influence of microRNAs in lithium response in bipolar disorder 3.058
Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients 3.048
Preliminary transcriptome analysis in lymphoblasts from cluster headache and bipolar disorder patients implicates dysregulation of circadian and serotonergic genes 3.042
Exploring the role of gut microbiota in major depressive disorder and in treatment resistance to antidepressants 3.012
Convergent analysis of genome-wide genotyping and transcriptomic data suggests association of zinc finger genes with lithium response in bipolar disorder 3.006
Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study 2.921
Association of polygenic score for major depression with response to lithium in patients with bipolar disorder 2.918
Exposure and duration of lithium treatment affect leukocyte telomere length in bipolar disorder patients 2.889
Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study 2.882
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.881
HDAC3 role in medication consumption in medication overuse headache patients: a pilot study 2.822
Involvement of core clock genes in lithium response 2.813
Differential effect of lithium on spermidine/spermine N1-acetiltransferase expression in suicidal behaviour 2.743
Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder. A genome-wide association study 2.710
Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients 2.677
Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease 2.676
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.671
Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: potential involvement of epigenetics 2.665
Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder 2.664
Increasing engagement in pharmacology and pharmacogenetics education using games and online resources: the PharmacoloGenius mobile app 2.645
null 2.498
Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder 2.450
Novel integrative genomic tool for interrogating lithium response in bipolar disorder 2.410
Pharmacogenomics of bipolar disorder 2.398
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample 2.375
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 2.349
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 2.299
Lithium pharmacogenetics: Where do we stand? 2.284
Mood Disorders, Accelerated Aging, and Inflammation: Is the Link Hidden in Telomeres? 2.229
Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder 2.186
Cellular models to study bipolar disorder: a systematic review 2.176
Age at onset in bipolar disorder: investigation of the role of TaqIA polymorphism of DRD2 gene in a Sardinian sample 2.148
Lithium-induced differential expression of SAT1 in suicide completers and controls is not correlated with polymorphisms in the promoter region of the gene 2.103
557. Pharmacogenetic Association of Lithium Treatment Response with Bcl2 Polymorphism in Bipolar Disorder 2.082
Characterisation of age and polarity at onset in bipolar disorder 2.022
An examination of the quality and performance of the Alda scale for classifying lithium response phenotypes 2.003
null 1.980
Assessment of response to lithium maintenance treatment in bipolar disorder: A Consortium on Lithium Genetics (ConLiGen) report 1.978
Variant GADL1 and response to lithium in bipolar I disorder 1.971
MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings 1.933
Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals 1.886
Lithium pharmacogenetics 1.859
Positive Association Between REV-ERB Alpha Gene and Bipolar Disorder in a Sardinian Population 1.847
A genetic risk score is differentially associated with migraine with and without aura 1.846
null 1.842
Candidate Genes in Bipolar 1 Sradinian Patients : A case control Study 1.818
The international consortium on lithium genetics (ConLiGen): An initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment 1.790
Doctors and researchers: integrating data for bipolar disorder studies 1.763
Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI 1.721
Zinc finger proteins in psychiatric disorders and response to psychotropic medications 1.673
Golden Helix Pharmacogenomics Days: educational activities on pharmacogenomics and personalized medicine. 1.663
A European spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics 1.662
Leukocyte telomere length is reduced in patients with major depressive disorder 1.657
Prediction of lithium response using genomic data 1.645
Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors before Diagnosis: A Systematic Review 1.624
Treatment-Resistant Schizophrenia: Insights From Genetic Studies and Machine Learning Approaches 1.606
Insulin-like growth factor 1 differentially affects lithium sensitivity of lymphoblastoid cell lines from lithium responder and non-responder bipolar disorder patients 1.600
null 1.525
We are not alone in our body: insights into the involvement of microbiota in the etiopathogenesis and pharmacology of mental illness 1.517
Recent trends on the role of epigenomics, metabolomics and noncoding RNAs in rationalizing mood stabilizing treatment 1.503
null 1.449
null 1.424
null 1.414
A case-control association study of the PDLIM5 gene and bipolar disorder in a Sardinian sample 1.384
RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining 1.321
Telomere length in bipolar disorder and lithium response 1.308
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder 1.264
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia 1.263
RNA sequencing of bipolar disorder lymphoblastoid cell lines implicates the neurotrophic factor HRP-3 in lithium clinical efficacy 1.257
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.246
Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patiens 1.240
Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions 1.227
Genetic, demographic and archival study on a Sardinian village (Escalaplano) Italy 1.224
Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study 1.194
Haplotype association study between DRD1 gene and parasuicide in bipolar disorder: Analysis of two samples from Canada and Sardinia 1.194
The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine 1.185
Assessment of the pharmacogenomics educational environment in southeast europe 1.179
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease 1.164
null 1.161
null 1.156
null 1.146
Alzheimer’s disease: case-control study of polymorphisms in ACHE, CHAT and BCHE genes in a Sardininan sample 1.114
Investigation of the genetic interaction between BDNF and DRD3 genes in suicidical behaviour in psychiatric disorders 1.108
Candidate Genes in Bipolar 1 Sardinian Patients : A case control Study 1.059
The diacylglycerol kinase eta gene and bipolar disorder: a replication study in a Sardinian sample 1.054
Genetically elevated high-density lipoprotein cholesterol through cholesteryl ester transfer protein does not associate with risk of Alzheimer's disease 1.016
An introduction to pharmacogenomics and personalized medicine 1.013
HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders 1.013
Association study in a Sardinian sample between Bipolar Disorder and the nuclear receptor REV-ERBalpha gene, a critical component of the circadian clock system 1.011
A genome-wide association study of antidepressant-induced mania 984
2016 Golden Helix Summer School - Cancer Genomics and Individualized Therapy. 22-26 September 2016, Syros Island, Greece: Abstracts 980
Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy 971
Totale 201.774
Categoria #
all - tutte 310.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 310.173


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218.754 0 0 0 0 0 0 0 0 0 3.166 3.426 2.162
2021/202214.228 1.839 965 810 1.128 1.149 840 868 680 1.363 1.464 1.732 1.390
2022/202320.269 1.298 2.583 2.690 1.780 1.547 2.277 977 1.292 1.482 1.494 1.874 975
2023/202420.567 915 746 795 1.387 1.949 3.193 3.207 1.447 981 1.349 2.332 2.266
2024/202553.948 16.213 17.375 4.848 4.853 2.500 2.695 3.298 211 496 443 395 621
2025/202614.013 1.126 722 1.825 1.636 1.249 1.195 2.273 1.323 957 1.707 0 0
Totale 244.997